Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allakos Inc. - Common Stock (NQ:ALLK)

0.3291 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Allakos Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Gold Down 1%; PNC Financial Posts Upbeat Earnings ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The... 
Via Benzinga
Topics Stocks
News headline image
Where Allakos Stands With Analysts ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Allakos ↗
 
Via Benzinga
News headline image
Why Shares of Allakos Are Up Wednesday ↗
The stock is bouncing back from a recent 52-week low. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue ↗
U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to... 
Via Benzinga
Topics Stocks
News headline image
Why Is Allakos (ALLK) Stock Down 57% Today? ↗
Allakos stock is falling hard on Tuesday as investors in ALLK react to two of the company's Phase 2 clinical trials failing. 
Via InvestorPlace
News headline image
Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50% ↗
Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash... 
Via Benzinga
News headline image
Dow Dips 200 Points; Goldman Sachs Earnings Top Views ↗
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ... 
Via Benzinga
Topics Stocks
News headline image
Analyst Ratings for Allakos ↗
 
Via Benzinga
News headline image
Allakos: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Why Allakos Stock Was Heating Up Today ↗
A notable analyst upgrade had investors piling into this clinical-stage biotech stock today. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive ↗
Shares of Allakos Inc (NASDAQ: ALLK) were climbing in early trading on Monday. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning! 
Via InvestorPlace
News headline image
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside ↗
JMP Securities initiated coverage on Allakos Inc (NASDAQ: ALLK), noting novel monoclonal antibodies targeting Siglec (sialic acid immunoglobulin-like lectin) receptors on immune cells that are drivers... 
Via Benzinga
News headline image
Where Allakos Stands With Analysts ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗
 
Via Benzinga
News headline image
Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗
Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday. 
Via Benzinga
News headline image
Top 5 Health Care Stocks That Could Blast Off This Month ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Why Allakos Stock Skyrocketed Nearly 9% Higher Today ↗
The company is poised to report a critical set of clinical data in the coming months. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗
 
Via Benzinga
News headline image
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.